EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on Dietary Reference Values for niacin by 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014.
Scientific Opinion on Dietary Reference Values for niacin
EFSA Publication; Tetens, Inge
Link to article, DOI:
10.2903/j.efsa.2014.3759
Publication date:
2014
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
EFSA Publication (2014). EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014.
Scientific Opinion on Dietary Reference Values for niacin. Parma, Italy: Europen Food Safety Authority.  (The
EFSA Journal; No. 3759, Vol. 12(7)). DOI: 10.2903/j.efsa.2014.3759
  EFSA Journal 2014;12(7):3759 
 
Suggested citation: EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion 
on Dietary Reference Values for niacin. EFSA Journal 2014;12(7):3759, 42 pp. doi:10.2903/j.efsa.2014.3759 
Available online: www.efsa.europa.eu/efsajournal 
© European Food Safety Authority, 2014 
SCIENTIFIC OPINION 
Scientific Opinion on Dietary Reference Values for niacin
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies 
(NDA) derived Dietary Reference Values (DRVs) for niacin. Niacin is a generic term for nicotinic acid and 
nicotinamide. Niacin can be synthesised in the human body from the indispensable amino acid tryptophan. 
Approximately 60 mg of tryptophan yields 1 mg of niacin defined as 1 mg niacin equivalent (NE). Long-term 
inadequate intake of tryptophan and niacin can lead to the development of pellagra. In the absence of new 
scientific data, the Panel endorses the Average Requirement (AR) for adults of 1.3 mg  NE/MJ 
(5.5 mg NE/1 000 kcal) adopted by the Scientific Committee for Food (1993), based on data on urinary excretion 
of niacin metabolites as an endpoint. The Population Reference Intake (PRI) of 1.6 mg NE/MJ 
(6.6 mg NE/1 000 kcal) is derived from the AR assuming a coefficient of variation of 10 %. For infants aged 
7-11 months, children and adolescents, as well as for pregnant and lactating women, the Panel considers that 
there is no evidence that the relationship between niacin requirement and energy requirement differs from that of 
adults; therefore, the AR and PRI for adults are also applied to these age and life stage groups.  
© European Food Safety Authority, 2014 
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SUMMARY 
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition 
and Allergies (NDA) was asked to deliver a scientific opinion on Dietary Reference Values for the 
European population, including niacin.  
Niacin is a generic term for nicotinic acid and nicotinamide, soluble organic compounds that belong 
to the group of B vitamins. Niacin is found in a wide range of foods. Main food groups contributing to 
niacin intakes of adults include meat and meat products, grains and grain-based products and milk and 
milk products. Depending on the foodstuff, the mean absorption of niacin is from about 23 % to about 
70 %; it is lowest from cereals and highest from animal products. Niacin can be synthesised in the 
human body from the indispensable amino acid tryptophan. Approximately 60 mg of tryptophan 
yields 1 mg of niacin defined as 1 mg niacin equivalent (NE). Inadequate iron, riboflavin or vitamin 
B6 status decreases the conversion of tryptophan to niacin.  
In vivo nicotinic acid is converted to nicotinamide, which is a precursor for nicotinamide adenine 
dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), which are essential to 
cells and involved in many biochemical reactions. Niacin circulates in the plasma as nicotinamide and 
nicotinic acid. Both forms are transported to cells and tissues, which they enter by diffusion to 
perform the intracellular functions of niacin. Niacin is trapped within the cell as NAD or NADP.  
The major pathway of catabolism of nicotinic acid and nicotinamide is by methylation in the liver to 
N-methyl-nicotinamide (NMN) and subsequent oxidation to N-methyl-2-pyridone-carboxamide 
(2-Pyr) and N-methyl-4-pyridone-carboxamide (4-Pyr). In humans, the two major excretion products 
are NMN and 2-Pyr, which under normal conditions represent about 20-35 % and 45-60 % of niacin 
metabolites, respectively. The amount of niacin metabolites excreted depends on the niacin and 
tryptophan intake. Long-term inadequate intake of tryptophan and niacin results in reduced urinary 
excretion of niacin metabolites, and can lead to the development of pellagra. Based on experimental 
studies on niacin deficiency, it is recognised that niacin requirement is strongly dependent on energy 
intake. No signs of niacin deficiency were observed in subjects on diets containing at least 
approximately 1 mg NE/MJ (4.4 mg NE/1 000 kcal), while providing no less than 8.4 MJ/day 
(2 000 kcal/day). Diets providing at least 1.3 mg NE/MJ (5.5 mg NE/1 000 kcal) were sufficient to 
prevent depletion and maintain niacin body stores, as indicated by a sharp increase in urinary 
excretion of niacin metabolites above this intake.  
The Panel notes that no new scientific data that would necessitate an amendment of the DRVs for 
niacin have become available since the publication of the Scientific Committee for Food (SCF) report 
in 1993. The Panel therefore endorses the relationship proposed by SCF (1993) between niacin 
requirement and energy requirement. 
The Panel endorses the Average Requirement (AR) for adults (men and women) of 1.3 mg NE/MJ 
(about 5.5 mg NE/1 000 kcal) and the Population Reference Intake (PRI) of 1.6 mg NE/MJ (about 
6.6 mg NE/1 000 kcal) adopted by SCF (1993) assuming a coefficient of variation of 10 %. The Panel 
considers that there is no evidence that the relationship between niacin requirement and energy 
requirement for infants aged 7-11 months, children and adolescents differs from that of adults. 
Therefore, the AR and PRI for adults are applied to these age groups as well. The Panel also considers 
that, in pregnant and lactating women, there is no evidence that the relationship between niacin 
requirement and energy requirement differs from that of other adults. Therefore, the AR and PRI for 
adults are applied to these life stage groups. Taking into account the reference energy intake, i.e. the 
AR for energy for various Physical Activity Levels (PAL values), the intake of NE/MJ is also 
expressed as mg NE/day. The Panel notes that, as for other nutrient reference values, DRVs for niacin 
are set under the assumption that intakes of other essential nutrients, particularly iron, riboflavin, 
vitamin B6 and protein, and energy are adequate. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The scientific advice on nutrient intakes is important as the basis of Community action in the field of 
nutrition, for example such advice has in the past been used as the basis of nutrition labelling. The 
Scientific Committee for Food (SCF) report on nutrient and energy intakes for the European 
Community dates from 1993. There is a need to review and if necessary to update these earlier 
recommendations to ensure that the Community action in the area of nutrition is underpinned by the 
latest scientific advice.  
In 1993, the SCF adopted an opinion on the nutrient and energy intakes for the European 
Community.
4
 The report provided Reference Intakes for energy, certain macronutrients and 
micronutrients, but it did not include certain substances of physiological importance, for example 
dietary fibre. 
Since then new scientific data have become available for some of the nutrients, and scientific advisory 
bodies in many European Union Member States and in the United States have reported on 
recommended dietary intakes. For a number of nutrients these newly established (national) 
recommendations differ from the reference intakes in the SCF (1993) report. Although there is 
considerable consensus between these newly derived (national) recommendations, differing opinions 
remain on some of the recommendations. Therefore, there is a need to review the existing EU 
Reference Intakes in the light of new scientific evidence, and taking into account the more recently 
reported national recommendations. There is also a need to include dietary components that were not 
covered in the SCF opinion of 1993, such as dietary fibre, and to consider whether it might be 
appropriate to establish reference intakes for other (essential) substances with a physiological effect. 
In this context the EFSA is requested to consider the existing Population Reference Intakes for 
energy, micro- and macronutrients and certain other dietary components, to review and complete the 
SCF recommendations, in the light of new evidence, and in addition advise on a Population Reference 
Intake for dietary fibre.  
For communication of nutrition and healthy eating messages to the public it is generally more 
appropriate to express recommendations for the intake of individual nutrients or substances in food-
based terms. In this context the EFSA is asked to provide assistance on the translation of nutrient 
based recommendations for a healthy diet into food based recommendations intended for the 
population as a whole.  
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Article 29 (1)(a) and Article 31 of Regulation (EC) No. 178/2002,
5
 the 
Commission requests EFSA to review the existing advice of the Scientific Committee for Food on 
population reference intakes for energy, nutrients and other substances with a nutritional or 
physiological effect in the context of a balanced diet which, when part of an overall healthy lifestyle, 
contribute to good health through optimal nutrition.  
In the first instance the EFSA is asked to provide advice on energy, macronutrients and dietary fibre. 
Specifically advice is requested on the following dietary components:  
 Carbohydrates, including sugars; 
                                                     
4  Scientific Committee for Food, Nutrient and energy intakes for the European Community, Reports of the Scientific 
Committee for Food 31st series, Office for Official Publication of the European Communities, Luxembourg, 1993. 
5  Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general 
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in 
matters of food safety. OJ L 31, 1.2.2002, p. 1-24. 
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 Fats, including saturated fatty acids, polyunsaturated fatty acids and monounsaturated fatty 
acids, trans fatty acids; 
 Protein; 
 Dietary fibre. 
Following on from the first part of the task, the EFSA is asked to advise on population reference 
intakes of micronutrients in the diet and, if considered appropriate, other essential substances with a 
nutritional or physiological effect in the context of a balanced diet which, when part of an overall 
healthy lifestyle, contribute to good health through optimal nutrition. 
Finally, the EFSA is asked to provide guidance on the translation of nutrient based dietary advice into 
guidance, intended for the European population as a whole, on the contribution of different foods or 
categories of foods to an overall diet that would help to maintain good health through optimal 
nutrition (food-based dietary guidelines). 
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ASSESSMENT 
1. Introduction 
Niacin is a generic term for nicotinic acid and nicotinamide, which are water-soluble organic 
compounds that belong to the group of B vitamins. Both compounds are identical in their vitamin 
function. Niacin can be obtained from food as well as being produced in the liver from the 
indispensable amino acid tryptophan.  
In 1993, the Scientific Committee for Food (SCF) adopted an opinion on nutrient and energy intakes 
for the European Community (SCF, 1993). For niacin, SCF set Population Reference Intakes (PRIs) 
for adults and children, as well as an Average Requirement (AR) and a Lowest Threshold Intake 
(LTI) for adults. 
2. Definition/category 
Nicotinic acid has a molecular mass of 123.11 Da and nicotinamide has a molecular mass of 
122.11 Da. Nicotinamide is more soluble in water than nicotinic acid. Nicotinamide is a constituent of 
nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP). 
Both of these can accept a hydrogen ion (H
+
) and two electrons (namely a hydride anion, H
-1
) to form 
NADH and NADPH, and may be involved in redox reactions as electron acceptors (NAD, NADP) or 
donors (NADH, NADPH). 
2.1. Functions of niacin 
2.1.1. Biochemical functions 
The function of niacin is as the precursor of the nicotinamide nucleotide coenzymes NAD and NADP, 
which are involved in oxidation/reduction reactions and associated with both catabolic and anabolic 
processes.  
Many dehydrogenases use NAD or NADP or both. Generally, NAD-linked dehydrogenases catalyse 
redox reactions of the oxidative pathways of metabolism, particularly in glycolysis, the citric acid 
cycle and the respiratory chain of mitochondria. NADP-linked dehydrogenases are characteristically 
found in reductive biosynthesis, as in the pathway of fatty acid and steroid synthesis, and also in the 
pentose-phosphate pathway. Therefore, NAD is essential for energy-producing reactions and NADP 
for anabolic reactions. NAD also participates in unique non-redox adenosine diphosphate–ribose 
transfer reactions involved in protein modification, calcium mobilisation, cell signaling and DNA 
repair (Kim et al., 1993; Malanga and Althaus, 2005; Sauve et al., 2006; Belenky et al., 2007; Bogan 
and Brenner, 2008; Kirkland, 2014).  
2.1.2. Health consequences of deficiency and excess 
2.1.2.1. Deficiency 
Long-term inadequate intake of tryptophan and niacin can lead to the development of pellagra. The 
common symptoms of pellagra include photosensitive dermatitis, skin lesions, tongue and mouth 
soreness, vomiting, diarrhoea, depression and dementia. Early symptoms are usually non-specific and 
include weakness, loss of appetite, fatigue, digestive disturbances, abdominal pain and irritability. 
Untreated pellagra results in death from multiorgan failure (Hegyi et al., 2004; Wan et al., 2011). 
Dietary Reference Values for niacin 
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In industrialised countries, pellagra is rare. It may be observed when conditions or diseases interfere 
with niacin intake, absorption and/or metabolism, e.g. in chronic alcohol abuse or in patients with 
anorexia nervosa or gastrointestinal diseases characterised by malabsorption or disturbances in 
tryptophan metabolism (Wan et al., 2011). 
2.1.2.2. Excess 
The Tolerable Upper Intake Level (UL) for free nicotinic acid is 10 mg/day, and the UL for 
nicotinamide is 900 mg/day in adults (SCF, 2002). These ULs are not applicable during pregnancy or 
lactation because of insufficient data.  
The UL for nicotinic acid is based on data indicating occasional flushing at an intake of 30 mg/day 
(Sebrell and Butler, 1938), using an uncertainty factor of three to allow for the fact that a slight effect 
(occasional flushing) was reported and that the study was performed in a small number of subjects but 
taking into account the steep dose–response relationship. For nicotinamide, the No Observed Adverse 
Effect Level (NOAEL) of 25 mg/kg body weight per day reported in patients with diabetes (Pozzilli et 
al., 1995) was used, and an uncertainty factor of two was applied to allow for the fact that adults may 
eliminate nicotinamide more slowly than the study groups, many of which were children. 
2.2. Physiology and metabolism 
2.2.1. Intestinal absorption 
Intestinal absorption of nicotinic acid and nicotinamide supplied from food is mediated by sodium 
ion-dependent, carrier-mediated diffusion, but a role for the human organic anion transporter 10 
(hOAT10) and the intracellular protein–tyrosine kinase pathway has also been proposed (Evered et 
al., 1980; Nabokina et al., 2005; Said et al., 2007; Bahn et al., 2008; Said, 2011). 
Depending on the foodstuff, the mean absorption of niacin is from about 23 % to 70 %; it is lowest 
from cereals and highest from animal products (Carter and Carpenter, 1982; Wei, 1982; Wall et al., 
1987). In order to be absorbed, NAD and NADP from the diet need to be hydrolysed in the intestine 
into nicotinamide (Henderson, 1983; Gropper et al., 2009). In cereals, niacin is mostly present as 
esterified forms unavailable for absorption, namely niacytin consisting of nicotinic acid esterified to 
polysaccharides, and also to polypeptides and glycopeptides (niacinogenes) (Wall et al., 1987; Ball, 
1998). The majority (about 75 %) of this bound nicotinic acid is biologically unavailable after 
cooking and only a small part (less than about 25 %) of these bound forms may become hydrolysed by 
gastric acid (Carter and Carpenter, 1982). The bioavailability of bound forms of niacin can be 
increased by pretreatment of the food with alkali for ester bond hydrolysis (Mason et al., 1973; Carter 
and Carpenter, 1982; Carpenter and Lewin, 1985).  
2.2.2. Transport in blood and distribution to tissues 
Niacin circulates in the plasma as nicotinamide and nicotinic acid (Pollak et al., 2007; Kirkland, 
2009). Nicotinamide is the major form of niacin found in the bloodstream (Kirkland, 2009). From the 
blood, nicotinic acid and nicotinamide move across cell membranes by simple diffusion; however, the 
transport into the kidney tubules and erythrocytes requires a carrier (Henderson, 1983; Gropper et al., 
2009).  
2.2.3. Metabolism 
Niacin can be synthesised in the human body from the indispensable amino acid tryptophan. 
Approximately 60 mg of tryptophan yields 1 mg of niacin, as reviewed by Horwitt et al. (1981); 
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because of this conversion ratio, 60 mg of tryptophan has been defined as 1 mg niacin equivalent 
(NE). The conversion of tryptophan to niacin depends on tryptophan intake rather than on niacin 
status; when dietary tryptophan is limited, the efficiency of conversion of tryptophan to niacin falls 
below the commonly used conversion ratio, because of the priority for the use of dietary tryptophan in 
protein synthesis (Vivian et al., 1958; Patterson et al., 1980; Bender, 2003; Kirkland, 2007). 
Inadequate iron, riboflavin, or vitamin B6 status decreases the conversion of tryptophan to niacin 
(McCormick, 1989). Inter-individual differences (about 30 %) in the conversion efficiency of 
tryptophan to niacin have been reported (Patterson et al., 1980; Horwitt et al., 1981). The conversion 
of tryptophan to niacin is more efficient in pregnant women than in other adults (Wertz et al., 1958); 
this is supported by data collected during pregnancy in animals (Ftukijwatari et al., 2004). However, 
the tryptophan to niacin conversion ratio would need to be confirmed by other studies in pregnant 
women. The conversion of tryptophan to niacin is reduced under certain conditions such as carcinoid 
syndrome and as a result of decreased absorption of tryptophan in Hartnup‟s disease and other 
conditions associated with malabsorption, as well as prolonged treatment with certain drugs (Hegyi et 
al., 2004; Wan et al., 2011). 
Within the cell, niacin is used to synthesise NAD, which can then be phosphorylated to NADP, and 
both of these can accept two electrons and one proton to form NADH and NADPH. Humans use both 
nicotinamide and nicotinic acid to synthesise NAD but utilise different pathways to achieve this 
(Bogan and Brenner, 2008; Sauve, 2008; Kirkland, 2009). Nicotinamide is converted to NAD by 
reaction with 5-phosphoribosyl-1-pyrophosphate and ATP. Nicotinic acid reacts with 
5-phosphoribosyl-1-pyrophosphate and forms the nicotinic acid mononucleotide, which is then 
transformed into nicotinic acid dinucleotide by adenylation, and subsequently converted to NAD by 
amidation in the presence of glutamine (Bogan and Brenner, 2008; Sauve, 2008; Kirkland, 2009). 
NAD is converted to NADP by reaction with ATP. Intracellular concentrations of NAD are generally 
higher than NADP concentrations (Srikantia et al., 1968; Fu et al., 1989; Sauve, 2008; Gropper et al., 
2009; Kirkland, 2009). 
The major pathway of catabolism of nicotinic acid and nicotinamide is by methylation in the liver and 
subsequent oxidation. Both compounds are metabolised to N-methyl-nicotinamide (NMN) with the 
participation of ATP and Mg
2+
 and S-adenosylmethionine as a methyl donor. NMN can be oxidised to 
N-methyl-2-pyridone-carboxamide (2-Pyr)
6
 and N-methyl-4-pyridone-carboxamide (4-Pyr) (Bender, 
2003), which are found in both plasma and urine (see Sections 2.2.4.1. and 2.3.). 
2.2.4. Elimination 
The main route of niacin excretion is via the urine. There is no indication that faeces constitute an 
important route of excretion for absorbed niacin. 
2.2.4.1. Urine 
Once niacin is absorbed, niacin metabolites are excreted in urine. In humans the two major excretion 
products of niacin catabolism are NMN and 2-Pyr, which under normal conditions represent, 
respectively, about 20-35 % and 45-60 % of niacin metabolites in urine (Mrochek et al., 1976; Shibata 
and Matsuo, 1989; Gropper et al., 2009). Small amounts of 4-Pyr (about 6-9 % of niacin metabolites) 
are also excreted. The amount of niacin metabolites excreted depends on the niacin and tryptophan 
intake (see Sections 2.3 and 5.1.) (Goldsmith et al., 1952; Goldsmith et al., 1955; Horwitt et al., 1956; 
Jacob et al., 1989). Humans suffering from niacin deficiency have reduced renal excretion of 
metabolites (Goldsmith et al., 1955; Hegyi et al., 2004). Elevated urinary excretion of NMN and/or 
2-Pyr has been observed in pregnant women compared with non-pregnant women and in women 
                                                     
6  N-methyl-2-pyridone-carboxamide has also been referred to as 6-pyridone in some papers; in this Opinion the term 2-Pyr 
will be used consistently to refer to this compound. 
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compared with men, as well as in women taking oral contraceptives compared with control women 
(Horwitt et al., 1975). Urinary excretion of niacin metabolites was found to increase from early to late 
pregnancy and decline after childbirth (Wertz et al., 1958; Ftukijwatari et al., 2004). 
2.2.4.2. Breast milk 
Lactating women secrete niacin (nicotinamide and nicotinic acid) via their breast milk (Greer, 2001). 
Niacin concentrations in human milk from healthy mothers in the EU sampled at various stages of 
lactation are listed in Appendix A. Owing to the high protein turnover and the net positive nitrogen 
retention in infancy, tryptophan concentration in breast milk and its conversion to niacin by infants is 
not considered in this Section or in Appendix A. Using two UK studies (DHSS, 1977; Ford et al., 
1983), the mean concentration of niacin in mature human milk was about 2.1 mg/L. The niacin 
concentration in breast milk is reported to be dependent on maternal NE intake (Picciano, 2001). 
Considering a mean milk transfer of 0.8 L/day during the first six months of lactation in exclusively 
breastfeeding women (Butte et al., 2002; FAO/WHO/UNU, 2004; EFSA NDA Panel, 2009), and the 
mean concentration of niacin in mature human milk in the EU of about 2.1 mg/L, secretion of 
preformed niacin into milk during lactation is about 1.7 mg/day. 
2.3. Biomarkers  
2.3.1. Urinary niacin metabolites 
A significant linear correlation was observed between 24-hour urinary excretion of NMN, 2-Pyr, 
4-Pyr or the sum of the three metabolites and usual dietary intake of niacin and/or NE (mean intake of 
about 21-27 mg NE/day) in healthy men and women (18-27 years) (Shibata and Matsuo, 1989; Tsuji 
et al., 2010) and children (10-12 years) (Tsuji et al., 2011). A significant correlation between NE 
intakes and 24-hour urinary excretion of NMN and 2-Pyr (average of four days per subject) was also 
observed in three groups of young men (19-28 years) given 8 mg/day of niacin and different 
tryptophan doses (total intake of about 12-22 mg NE/day, each of the three doses being consumed for 
35 days) (Patterson et al., 1980). A dose-response relationship between NE intake and urinary 
excretion of niacin metabolites has also been observed in girls aged 7-9 years receiving diets 
providing between about 1.1 and 3.1 mg NE/MJ (Moyer et al., 1963; Miller and Abernathy, 1965). 
In seven healthy men on fixed diets containing between 6.1 and 32 mg NE/day during different study 
periods (one initial period of 13 days and three study periods of 35 or 15 days in which five study 
doses were tested), mean urinary excretion of 2-Pyr and NMN varied between about 1-20 mg/day and 
0.8-5 mg/day according to the dose, respectively (Jacob et al., 1989). For each metabolite, group mean 
urinary concentrations (n = 5) assessed at the end of each study period were significantly linearly 
correlated with mean NE intake. Urinary NMN excretion, but not 2-Pyr, was significantly lower in 
subjects with an intake of 6.1-10.1 mg NE/day than in those with an intake of 19.2-19.6 mg NE/day.  
A decrease in urinary excretion of the niacin metabolites NMN and 2-Pyr
7
 in subjects consuming 
different levels of NE is indicative of depleted body stores of niacin (Goldsmith et al., 1952; 
Goldsmith et al., 1955). Goldsmith et al. (1952) reported that no signs of pellagra were observed in 
subjects whose urinary NMN excretion remained above 0.9 mg/day, while the excretion decreased to 
about 0.5-0.7 mg/day in subjects with pellagra.  
The response of urinary excretion of niacin metabolites to oral test doses of nicotinamide may reflect 
niacin body stores. When an oral dose of nicotinamide (20 mg/70 kg body weight) was administered 
at the end of the initial period (19.6 mg NE/day), the “low” intake period (6.1-10.1 mg NE/day) and 
the “repletion” period (19.2 mg NE/day), urinary excretion of niacin metabolites assessed at one hour 
                                                     
7 Referred to as 6-pyridone in the paper. 
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pre-dose, then hourly for four hours post-dose indicated that increases in urinary NMN excretion 
above baseline values were similar according to diets, while urinary 2-Pyr excretion over four hours 
post-dose was significantly greater on the baseline diet compared with the other diets (Jacob et al., 
1989). In subjects with pellagra (Goldsmith et al., 1952), an increase in NMN excretion (from 0.5 to 
2.4-3.9 mg/day) and 2-Pyr excretion (from 0 to 14.3-21.3 mg/day) was observed in response to oral 
test doses of nicotinamide (50 mg), while a slow increase in urinary excretion of niacin metabolites 
was observed following daily administration of 2 mg nicotinamide or 3 mg tryptophan for 20-90 days. 
Niacin metabolites are excreted in the urine even at low NE intakes. For NE intakes above about 
11 mg/day, urinary excretion of niacin metabolites increased sharply, which has been suggested to 
reflect saturation of body stores (Goldsmith et al., 1955). 
The Panel notes that urinary excretion of niacin metabolites is considered as a marker of niacin status. 
However, there are only limited data available as to the suitability of urinary niacin metabolites as 
biomarkers of niacin intake.  
2.3.2. Plasma niacin metabolites  
In seven men consuming different amounts of NE (five study doses) (Jacob et al., 1989) (see Section 
2.3.1.), there was a significant linear relationship between group means (n = 5) of plasma NMN 
concentration at the end of each study period and the corresponding NE intake, but the only 
significant difference was observed between “low” (6.1 and 10.1 mg NE/day) and “high” NE diets 
(32 mg NE/day). A decrease in plasma 2-Pyr concentration to undetectable levels was observed with 
the two “low” NE diets, but there was no significant linear relationship between group means of 
plasma 2-Pyr concentration and NE intakes.  
The Panel notes that differences in plasma NMN concentrations reflect changes in niacin status 
associated with large changes in NE intake (6.1 to 32 mg NE/day) over periods of time. The Panel 
also notes that plasma niacin metabolites are less sensitive to changes in NE intakes than urinary 
metabolites. The Panel considers that the available data are too limited to judge on the suitability of 
plasma niacin metabolites as biomarker of niacin status.  
2.3.3. Erythrocyte pyridine nucleotides  
A decrease in NE intake is associated with a fall in whole blood pyridine nucleotide concentrations 
(Vivian et al., 1958). Fu et al. (1989) investigated the effect of varying NE intakes on erythrocyte 
NAD and NADP concentration. No significant difference in erythrocyte NAD concentration was 
observed between intakes of 6.1 and 10.1 mg NE/day after five weeks, but a significant decrease was 
observed compared with the initial intake of 19.6 mg NE/day. However, intakes of 25 and 32 mg 
NE/day did not significantly increase erythrocyte NAD after five weeks compared with the 
“repletion” intake of 19.2 mg NE/day. In contrast to erythrocyte NAD concentration, no significant 
change in erythrocyte NADP concentration was observed. 
The Panel notes that erythrocyte NAD concentration may be a marker of niacin depletion caused by 
“low” NE intake (≤ 10.1 mg NE/day); however, based on the limited data available no conclusion can 
be drawn on the relationship between erythrocyte NAD concentration and niacin requirement. 
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3. Dietary sources and intake data 
3.1. Dietary sources 
Niacin is found in a wide range of foods. The main sources of niacin include liver, meat and meat 
products, fish, peanuts and whole grains. Foods rich in protein, such as milk, cheese and eggs, which 
are good sources of the amino acid tryptophan, are therefore good sources of NEs. Coffee is also a 
source of niacin. In uncooked animal food, niacin occurs mainly in the form of the nucleotides NAD 
and NADP, and in plant food it is mostly present as esterified forms that require hydrolysis, which 
can occur during the course of food preparation (see Section 2.2.1). Niacin is temperature resistant; 
however, significant amounts of niacin can be lost in cooking water that is discarded.  
Currently, nicotinic acid and nicotinamide may be added to foods
8
 and food supplements.
9
 Inositol 
hexanicotinate (inositol hexaniacinate) may be added to food supplements
8
 only. The niacin content 
of infant and follow-on formulae is regulated.
10
 
3.2. Dietary intake 
Dietary intakes of niacin were estimated by the Evidence Management Unit (DATA) of EFSA using 
the EFSA Comprehensive Food Consumption Database (EFSA, 2011b) and the EFSA Food 
Composition Database. This assessment includes food consumption data from 12 dietary surveys 
(Appendix B) from nine countries (Finland, France, Germany, Ireland, Italy, Latvia, the Netherlands, 
Sweden and the UK), which were either already classified, or re-classified (French and Italian data), 
according to the FoodEx2 food classification system (EFSA, 2011a). The EFSA Food Composition 
Database was compiled during a procurement project (Roe et al., 2013) involving fourteen national 
food database compiler organisations, who were allowed to borrow compatible data from other 
countries in case no original composition data were available. This assessment on niacin includes 
food composition information from Finland, France, Germany, Italy, the Netherlands, Sweden and the 
UK. The amount of borrowed total niacin contents in these datasets were 6.4 % for Germany, 91 % 
for the UK, and 100 % for the others. For Ireland and Latvia, respectively, the UK and German food 
composition data were used. Total niacin content was directly available for 1 806 food terms of the 
food consumption data used in this assessment, and was missing for all included countries for 
503 food terms, to which either a value from another food (in case the food with missing value was 
consumed frequently or in high quantities or belonged to food groups with high concentration of 
niacin), or a zero value (otherwise), was attributed. 
After consistency checks and replacement of missing values for total niacin in the EFSA Food 
Composition Database, total niacin intakes, i.e. including preformed niacin (nicotinamide and 
nicotinic acid) and tryptophan (tryptophan content divided by a factor of 60), were calculated in 
mg NE/MJ and mg NE/day, for males (Appendix C) and females (Appendix D). Niacin intake 
calculations were performed only on subjects with at least two reporting days. Food consumption data 
of infants (6-11 months), either formula-fed or breast-fed, were provided by three studies. Human 
milk consumption data were available from the Italian survey, or could be calculated from the 
available German data, but not for the Finnish survey, thus the contribution of human milk to total 
niacin intakes of infants was calculated for Italy and Germany. Food consumption data in children 
were provided by nine studies, and data on adults by eight studies, including one on pregnant women 
                                                     
8  Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of 
vitamins and minerals and of certain other substances to foods, OJ L 404, 30.12.2006, p. 26. 
9  Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of 
the Member States relating to food supplements, OJ L 183, 12.7.2002, p. 51. 
10  Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending 
Directive 1999/21/EC, OJ L 401, 30.12.2006, p.1. 
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and adolescents. EFSA estimates are based on consumption of foods, either fortified or not (i.e. 
without dietary supplements).  
Average total niacin intakes ranged from 2.1 to 3.5 mg NE/MJ (8-11 mg NE/day) in infants. For 
children and adolescents, they ranged from 2.7 to 4.0 mg NE/MJ (12-20 mg NE/day) (1-< 3 years), 
from 2.8 to 4.8 mg NE/MJ (14-32 mg NE/day) (3-< 10 years) and from 3.2 to 5.2 mg NE/MJ (25-
41 mg NE/day) (10-< 18 years). In adults, average total niacin intakes ranged from 4.0 to 
5.4 mg NE/MJ (27-53 mg NE/day), and ranges varied from 2.5-3.9 mg NE/MJ at the lower end 
(5
th
 percentile) to 5.9-7.7 mg NE/MJ at the upper end (95
th
 percentile) of the intake distributions (from 
11.7-31.3 mg NE/day at the lower end to 37.3-78.2 mg NE/day at the upper end). Average daily 
intakes (but not energy-adjusted intakes) were slightly higher among males than females, mainly due 
to larger quantities of food consumed.  
Main food groups contributing to niacin intakes were calculated for males (Appendix E) and females 
(Appendix F): they included meat and meat products, grains and grain-based products, milk and dairy 
products, as well as human milk and foods classified under „food products for young population‟ for 
infants. Other important food groups contributing to niacin intake were composite dishes in Sweden 
and in the UK, fish and fish products among the elderly, especially in Sweden, coffee and cocoa 
beverages among Dutch, Finnish, Italian and Swedish adults, starchy roots or tubers and products 
thereof among Dutch children and adolescents, and alcoholic beverages in adult men in the UK, 
Ireland and the Netherlands. Differences in main contributors to niacin intakes between males and 
females were minor. 
EFSA‟s niacin intake estimates in mg/day were compared with published intakes from the same 
surveys and datasets in German children (Kersting and Clausen, 2003; Mensink et al., 2007), Irish 
(IUNA, 2011), Finnish (Helldán et al., 2013) and Swedish (Amcoff et al., 2012) adults, and UK 
subjects (Bates et al., 2011) (Table 1). Among infants in the VELS study (Kersting and Clausen, 
2003), the underestimation of, respectively, 19-24 % or 17-20 % in the average daily or energy-
adjusted intakes could be due to differences in the nutrient compositions between the German and the 
EFSA databases. The overestimation of the Swedish intakes and underestimation of the UK intakes 
may partly be due to the fact that data provided on composite dishes for these countries had been less 
disaggregated to ingredient level compared to other countries, and that UK intakes calculated over 
three years were compared with published results of the first two years of data collection.  
Comparisons were not undertaken for the other surveys, as there were no published niacin intake 
estimates for the Italian (Sette et al., 2011) or Dutch (van Rossum et al., 2011) surveys, as French 
published intakes were for preformed niacin (Afssa, 2009), as published intakes for Finnish 
adolescents (Hoppu et al., 2010) were for two days only (contrary to the EFSA dataset, see 
Appendix B), as published intakes for Finnish children (Kyttälä et al., 2010) included supplement 
consumption (contrary to the EFSA dataset), and as no matching publication was available for the 
Latvian survey. 
Table 1:  EFSA‟s average daily total niacin intake estimates, expressed as percentages of intakes 
reported in the literature 
Country % of published intakes (% range over different age classes in a specific survey) 
Finland  105-109 % (FINDIET2012) 
Germany 76-81 % (VELS, infants), 95-103 % (VELS, other age groups), 110-115 % (EsKiMo) 
Ireland  105-111 % (NANS) 
Sweden 114-121 % (Riksmaten) 
UK  82 – 97 % (NDNS-Rolling Programme, Years 1-3 )  
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Uncertainties in the estimates may be caused by inaccuracies in mapping food consumption data 
according to the FoodEx2 classification, in analysing or estimating niacin composition due to the use 
of borrowed values in the food composition database, and in replacing missing niacin values by 
values of similar foods or food groups. These inaccuracies may, in principle, cause both too high and 
too low estimates of total niacin intake. Overestimated values may also be related to differences in 
dealing with vitamin losses that might occur in processed foods. In this assessment on niacin, losses 
were based on the data for processed foods provided in the EFSA Food Composition Database project 
(Roe et al., 2013). 
4. Overview of Dietary Reference Values and recommendations 
4.1. Adults 
The Nordic countries (Nordic Council of Ministers, 2014) set an AR at 1.3 mg NE/MJ based on 
studies in which niacin status was assessed using urinary excretion of niacin metabolites (SCF, 1993; 
Powers, 1999). The Recommended Intake (RI) was set at 1.6 mg NE/MJ. This would correspond to an 
intake of about 13-15 mg NE/day for women and 15-19 mg NE/day for men. However, it was stated 
that, when planning diets, niacin intake should not be lower than 13 mg NE/day when a low energy 
diet (< 8 MJ/day) is consumed. A lower intake level was set at 1 mg NE/MJ, thus 9 mg NE/day for 
women and 12 mg NE/day for men. At energy intakes below 8 MJ/day, the lower limit was estimated 
to be 8 mg NE/day. 
The German-speaking countries (D-A-CH, 2013) followed a proposal by FAO/WHO (1978) to set 
niacin reference values in relation to energy intake as 1.6 mg NE/MJ and considered that niacin intake 
should not be below 13 mg NE/day in case of low energy requirement. Recommended intakes were 
calculated taking into account the guiding values for energy intake.  
WHO/FAO (2004) based their reference values on two studies (Patterson et al., 1980; Shibata and 
Matsuo, 1989), along with earlier data from the 1950s, considering 12.5 mg NE/day, which 
corresponds to 5.6 mg NE/4 184 kJ (5.6 mg NE/1 000 kcal or about 1.3 mg NE/MJ), as being 
minimally sufficient for niacin intake in adults.  
Afssa (2001) set a PRI of 6.0 mg NE/5 MJ (5.0 mg NE/1 000 kcal) derived from the minimum amount 
required to prevent pellagra and to restore normal excretion of NMN and 2-Pyr (Goldberger and 
Tanner, 1922; Goldsmith, 1956; Goldsmith et al., 1956; Horwitt et al., 1956; Jacob et al., 1989). 
Taking into account the mean energy intake for age and sex, reference values were set at 
14 mg NE/day for men and 11 mg NE/day for women. 
Based on three studies investigating the urinary excretion of NMN while on diets low or deficient in 
niacin (Goldsmith et al., 1955; Horwitt et al., 1956; Jacob et al., 1989), the Health Council of the 
Netherlands (2000) considered a urinary excretion of 1 mg/day of NMN to be the value below which 
niacin intake is inadequate. This value was judged to reflect an average intake of 11.6 mg NE/day at a 
normal protein intake (Goldsmith et al., 1952; Goldsmith et al., 1955; Horwitt et al., 1956; Jacob et 
al., 1989). It was concluded that there was no proven difference in the metabolism of niacin, but 
differences in energy intake between men (11.2 MJ/day) and women (8.5 MJ/day) were recognised 
(Hulshof et al., 1998). Therefore, an AR was set at 12 and 9 mg NE/day for men and women, 
respectively. A PRI of 17 mg NE/day for men and 13 mg NE/day for women aged 19 years or more 
was set.  
IOM (1998) considered urinary NMN excretion to be the best marker for setting the Estimated 
Average Requirement (EAR). Based on four experimental studies (Goldsmith et al., 1952; Goldsmith 
et al., 1955; Horwitt et al., 1956; Jacob et al., 1989), an interpolated urinary NMN excretion of 
1 mg/day was considered to reflect a niacin intake that is above the intake resulting in deficiency, and 
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a corresponding NE intake was calculated assuming a linear relationship between NMN excretion and 
niacin intake. The average (± SD) intake equivalent to the excretion of 1 mg NMN/day was calculated 
to be 11.6 ± 3.9 mg NE. The EAR was set at 12 mg NE/day for men and, with a small (approximately 
10 %) decrease for the lower energy intake of women, at 11 mg NE/day for women. For the 
Recommended Dietary Allowance (RDA), a coefficient of variation (CV) of 15 % was used, as the 
data from the four experimental studies suggested a wider variation than 10 %, resulting in an RDA of 
16 and 14 mg NE/day for men and women, respectively. 
SCF (1993) based the AR of 1.3 mg NE/MJ on the results of depletion–repletion studies in which the 
amount of preformed niacin or tryptophan required to restore “normal” excretion of NMN and methyl 
pyridone carboxamide was determined (Horwitt et al., 1956; Kelsay, 1969).
11,12
 Allowing for 
individual variation, the PRI was set at 1.6 mg NE/MJ, which was then expressed as mg NE/day based 
on the AR for energy derived by SCF (1993)
13
. SCF considered people on “low energy diets” and 
concluded that the requirement of subjects with usual intakes below 8 MJ/day may not be covered by 
the PRI of 1.6 mg NE/MJ and thus suggested a PRI of 13 mg NE/day for these subjects. The LTI was 
set at 1.0 mg NE/MJ.  
The UK Committee on Medical Aspects of Food (COMA) (DH, 1991) based the AR of 
5.5 mg NE/1 000 kcal (i.e. 1.3 mg NE/MJ) on the requirement for niacin to prevent or cure pellagra, 
or to normalise urinary excretion of NMN and of methyl pyridine carboxamide, in subjects 
maintained on niacin-deficient diets and in energy balance (Horwitt et al., 1956). Applying a CV of 
10 %, a PRI of 6.6 mg NE/1 000 kcal (i.e. 1.6 mg NE/MJ) and a Lower Reference Nutrient Intake of 
4.4 mg NE/1 000 kcal (i.e. about 1 mg NE/MJ) were derived. 
An overview of DRVs for niacin for adults is presented in Table 2. 
                                                     
11 The narrative review by Kelsay (1969) reported that an excretion of 0.5 mg NMN/g creatinine was found in subjects with 
daily intakes of about 5 mg niacin and 200 mg tryptophan (a total of 8.3 mg NE) when subjects began to show clinical 
evidence of pellagra (Interdepartmental Committee on Nutrition for National Defense, 1963. Manual for Nutrition 
Surveys, 249 pp.). 
12 Although they are not referenced in the SCF report on niacin, it is assumed in this Opinion that the data of Goldsmith 
(1952, 1955) were used in setting the AR and PRI. 
13 In its opinion on energy intakes for the European Community, SCF (1993) indicated that, when an average energy intake 
was used for converting reference values for nutrients expressed in µg or mg/MJ to values in mg/day, a value of 11.3 
MJ/day for adult men and of 8.5 MJ/day for adult women were used, which were the mean for men and for women of the 
energy requirements calculated for four age classes (considering resting energy expenditure based on available observed 
body weights but without considering desirable physical activity). 
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Table 2:  Overview of Dietary Reference Values for niacin for adults  
 NNR 
2012 
(a)
 
D-A-CH 
(2013) 
(a) 
WHO/FAO 
(2004) 
(b)
 
Afssa 
(2001) 
(c)
 
NL 
(2000) 
IOM 
(1998)
 
SCF 
(1993) 
DH 
(1991) 
Age (years) 18-30 19-< 25 ≥ 19 ≥ 20 ≥ 19 ≥ 19 ≥ 18 ≥ 19 
PRI Men (mg NE/day) 19 17 16 14 17 16 1.6 
(d)
 1.6 
(d)
 
PRI Women (mg NE/day) 15 13 14 11 13 14 1.6 
(d)
 1.6 
(d)
 
Age (years) 31-60 25-< 51       
PRI Men (mg NE/day) 18 16       
PRI Women (mg NE/day) 14 13       
Age (years) 61-74 51-< 65       
PRI Men (mg NE/day) 16 15       
PRI Women (mg NE/day) 13 13       
Age (years) ≥ 75 ≥ 65       
PRI Men (mg NE/day) 15 13       
PRI Women (mg NE/day) 13 13       
(a): PRI of 1.6 mg NE/MJ (Nordic Council of Ministers, 2014). 
(b): from a “minimally sufficient” amount of 1.3 mg NE/MJ. 
(c): PRI of 1.2 mg NE/MJ. 
(d): Expressed as mg NE/MJ. 
NE: niacin equivalent (1 mg niacin = 1 niacin equivalent = 60 mg dietary tryptophan). 
NL: Health Council of the Netherlands (2000). 
4.2. Infants and children 
The Nordic countries (Nordic Council of Ministers, 2014) used the adult RI of 1.6 mg NE/MJ to set 
RIs for infants and children over six months of age, adjusted for the reference energy intake values for 
children. 
The German-speaking countries (D-A-CH, 2013) followed the proposal by FAO/WHO (1978) to set 
niacin DRVs in relation to energy intake as 1.6 mg/MJ for the derivation of recommended intakes for 
infants older than four months and children. 
For infants aged 7-12 months, WHO/FAO (2004) calculated the requirement based on a niacin 
concentration of human milk of 1.5 mg/L and a tryptophan concentration of 210 mg/L (American 
Academy of Pediatrics Committee on Nutrition, 1985). Therefore, it was calculated that the total 
content of NE is approximately 5 mg/L or 4 mg NE/0.75 L of human milk consumed daily. PRIs for 
children were set, but no information was given on how the PRIs were derived. 
For infants from birth to 12 months, Afssa (2001) recommended a daily intake of about 3 mg NE 
based on the average concentration of niacin and tryptophan in breast milk and a mean milk intake of 
0.75 L/day. No data were found on which to base niacin requirements for children; therefore, 
requirements were adjusted from the adult values of 5 mg NE/1 000 kcal, considering the average 
energy requirements of children. The values derived for adolescents were the same as for adults. 
The Health Council of the Netherlands (2000) set an Adequate Intake (AI) of 2 mg/day of niacin for 
infants from birth to five months based on an average concentration of niacin in breast milk of 
2.1 mg/L (Fomon and McCormick, 1993). It was proposed that, as infants require tryptophan for 
protein metabolism, only preformed niacin would be considered in the derivation of the AI. For 
infants and children older than six months, no data were identified; therefore, the AI was calculated 
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by linear extrapolation between the AI of infants from birth to five months and the value of adults. An 
AI of 2 mg NE/day for infants aged 6-11 months was set.  
For infants between birth and six months, IOM (1998) derived an AI for niacin based on the estimated 
niacin concentration of breast milk of 1.8 mg/L (Ford et al., 1983) and the reported mean intake of 
breast milk for this age group of 0.78 L/day (Hofvander et al., 1982; Butte et al., 1984; Chandra, 
1984; Allen et al., 1991). Because of the high rate of protein turnover and the net positive nitrogen 
retention in infancy, tryptophan intake was not considered. Therefore, an AI was set at 2 mg/day of 
preformed niacin, after rounding up. For infants aged 7-12 months, an AI (in mg NE/day) was 
extrapolated from estimates of adult requirement by allometric scaling, using body weight to the 
power of 0.75 (and rounding). For children and adolescents, no data were found on which to base an 
EAR; therefore, EARs and RDAs were extrapolated from adults by allometric scaling. 
For infants and children, SCF (1993) and UK COMA (DH, 1991) considered that there was no 
evidence that the requirement was different from that of adults, other than on the basis of average 
energy expenditure. 
An overview of DRVs for niacin for children is presented in Table 3. 
Table 3:  Overview of Dietary Reference Values for niacin for children 
 NNR 
2012
(a)
 
D-A-CH 
(2013)
 
WHO 
(2004) 
Afssa 
(2001) 
NL 
(2000) 
IOM 
(1998)
 
SCF  
(1993) 
DH 
(1991) 
Age (months) 6-11 4-< 12 7-12 infants 6-11 7-12 6-11 7-12 
PRI (mg NE/day) 5 5 4 
(b)
 3 
(b)
 2 
(b)
 4 
(b)
 1.6
 (c)
 1.6 
(c)
 
Age (years) 1-< 2 1-< 4 1-3 1-3 1-3 1-3 1-17 1-18 
PRI (mg NE/day) 7 7 6 6 4 
(b)
 6  1.6
 (c)
 1.6 
(c)
 
Age (years) 2-5 4-< 7 4-6 4-6 4-8 4-8   
PRI (mg NE/day) 9 10 8 8 7 
(b)
 8   
Age (years) 6-9 7-< 10 7-9 7-9 9-13 9-13   
PRI (mg NE/day) 12 12 12 9 11 
(b)
 12   
Age (years) 10-13 10-< 13 10-18 10-12 14-18 14-18   
PRI Boys (mg NE/day) 15 15 16 10 17 
(b)
 16   
PRI Girls (mg NE/day) 14 13 16 10 13 
(b)
 14   
Age (years) 14-17 13-< 15  13-15     
PRI Boys (mg NE/day) 19 18  13     
PRI Girls (mg NE/day) 16 15  11     
Age (years)  15-< 19  16-19     
PRI Boys (mg NE/day)  17  14     
PRI Girls (mg NE/day)  13  11     
(a): Nordic Council of Ministers (2014). 
(b): AI. 
(c): Expressed as mg NE/MJ. 
NE: niacin equivalent. NL: Health Council of the Netherlands (2000). 
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4.3. Pregnancy and lactation 
The Nordic countries (Nordic Council of Ministers, 2014) recommended an additional 1 mg NE/day 
(girls aged 14-17 years) to 3 mg NE/day (women of 31 years and older) for pregnant women, based on 
the increased energy requirement, and thus set an RI of 17 mg/day for pregnancy. They recommended 
an extra intake of 4 mg NE/day (girls aged 14-17 years) to 6 mg NE/day (women of 31 years and 
older), based on the niacin content of breast milk and the increased energy requirement, and thus set 
an RI of 20 mg/day for lactation. 
The German-speaking countries (D-A-CH, 2013) acknowledged that the formation of niacin from 
tryptophan is increased during pregnancy. Nevertheless, and taking into account the increased energy 
requirement in pregnancy, an additional intake of 2 mg NE/day was recommended; thus a PRI of 
15 mg/day for pregnancy was set. The German-speaking countries assumed that 1.3 mg preformed 
niacin and 2.8 mg NE from tryptophan are secreted with 0.75 L of milk per day. Therefore, an 
additional intake of 4 mg NE/day was recommended for lactating women; thus the PRI was set at 
17 mg/day. 
Considering the energy requirement for non-pregnant women and that of the entire pregnancy, 
WHO/FAO (2004) calculated that the niacin requirement above that of non-pregnant women was 
308 mg NE (5.6 mg NE/4 184 kJ) for the entire pregnancy or 1.7 mg NE/day for the second and third 
trimesters. In addition, about 2 mg NE/day was assumed to be required for growth in maternal and 
fetal compartments (IOM, 1998). Thus, the PRI was set at 18 mg/day for pregnancy. WHO/FAO 
(2004) estimated that 1.4 mg preformed niacin is secreted daily with breast milk, and that an 
additional amount of less than 1 mg is required to support the energy expenditure of lactation. Hence, 
it was assumed that lactating women require an additional 2.4 mg NE/day. Thus, the PRI was set at 
17 mg/day. 
For pregnant women, Afssa (2001) advised an increase of 5 mg NE/day to meet the increased energy 
needs of pregnancy, setting a PRI of 16 mg NE/day. Afssa also advised an increase of 4 mg NE/day to 
cover the amount secreted with milk, proposing a PRI of 15 mg NE/day for lactating women. 
The Health Council of the Netherlands (2000) based its reference values on increased energy 
consumption (equivalent to 1 mg NE/day) and the growth of tissue in the mother and fetal 
compartments (2 mg NE/day). Using the factorial method, an AR of 12 mg NE/day and a PRI of 
17 mg NE/day were set. The Health Council of the Netherlands (2000) set an AR of 14 mg NE/day 
for lactating women based on the average daily loss of 2 mg/day of niacin in breast milk and increased 
energy needs for milk production equivalent to 3 mg NE/day, which were added to the AR for non-
lactating women. A PRI of 20 mg NE/day was set for lactating women. 
IOM (1998) found no direct evidence to suggest a change in niacin requirement during pregnancy but 
estimated an increase of 3 mg NE/day (added to the EAR of non-pregnant women) to cover increased 
energy utilisation and growth of maternal and fetal compartments, especially during the second and 
third trimesters; thus, using a CV of 15 %, an RDA of 18 mg NE/day was set. IOM estimated that 
1.4 mg of preformed niacin is secreted daily during lactation. Therefore, along with an amount of 
1 mg to cover the energy expenditure of milk production, an additional 2.4 mg NE/day was 
recommended for women exclusively breastfeeding, added to the EAR for non-lactating women and 
rounded down, to result in an RDA of 17 mg/day. 
SCF (1993) concluded that there was no need for an increased niacin intake in pregnancy as the 
hormonal changes associated with pregnancy increased the efficiency of synthesis of nicotinamide 
nucleotides from tryptophan. SCF considered an increase in intake of 2 mg NE/day to allow for the 
niacin secreted in milk. 
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UK COMA (DH, 1991) concluded that it was unnecessary to increase niacin intake during pregnancy 
as the additional requirement would be met by changes in the metabolism of tryptophan (Wertz et al., 
1958). Based on a preformed niacin concentration of 2.7 mg/L in mature human milk, UK COMA 
recommended an increment of 2.3 mg NE/day in addition to the PRI for non-pregnant women. 
An overview of DRVs for niacin for pregnant and lactating women is presented in Table 4. 
Table 4:  Overview of Dietary Reference Values for niacin for pregnant women 
 NNR 
2012 
(a)
 
D-A-CH 
(2013) 
WHO/FAO 
(2004) 
Afssa 
(2001) 
NL 
(2000) 
(b)
 
IOM 
(1998)
 (c)
 
SCF 
(1993)
 
 
DH 
(1991) 
PRI for pregnancy 
(mg NE/day) 
17 15 
(d)
 18 16 17 18 1.6 
(e)
 1.6 
(e)
 
PRI for lactation 
(mg NE/day) 
20 17 17 15 20 17 + 2 + 2.3 
(a): Nordic Council of Ministers (2014). 
(b): Taken from the original Dutch table, not the English summary. 
(c): Age 14-50 years. 
(d): From four months.  
(e): Expressed as mg NE/MJ. 
NE: niacin equivalent.  
NL: Health Council of the Netherlands (2000). 
5. Criteria (endpoints) on which to base Dietary Reference Values 
5.1. Indicators of niacin requirement  
5.1.1. Adults 
5.1.1.1. Pellagra 
In a depletion–repletion study on seven healthy men (23-39 years, n = 12 included, five drop-outs) 
(Jacob et al., 1989), all subjects received an initial diet containing about 10.5 MJ/day and 
19.6 mg NE/day for 13 days (1.9 mg NE/MJ or 7.8 mg NE/1 000 kcal), then consumed one of two 
“low” NE diets, either 6.1 mg NE/day (0.58 mg NE/MJ or 2.44 mg NE/1 000 kcal) or 10.1 mg NE/day 
(about 0.97 mg NE/MJ or 4 mg NE/1 000 kcal) for 35 days. Energy intakes were individually adjusted 
for maintenance of body weight. No signs of pellagra were observed in these subjects. 
Goldsmith et al. (1952) carried out a study in seven women with psychoneurosis (aged 25-54 years), 
who consumed either a “corn” diet14, which provided daily 4.7 mg niacin, 190 mg tryptophan and 
8.4 MJ, thus about 0.94 mg NE/MJ (3.9 mg NE/1 000 kcal), or a “wheat” diet, which provided daily 
5.7 mg niacin, 230 mg tryptophan and 7.9 MJ, thus about 1.2 mg NE/MJ (5 mg NE/1 000 kcal). The 
energy content of the diets was adjusted to meet the subjects‟ energy requirements. In the first phase 
of the experiment on three subjects, no signs of pellagra were observed either on the corn diet (n = 2) 
for 40 and 42 days or on the wheat diet (n = 1) for 95 days. Three other subjects then followed the 
corn diet for 81, 135 and 111 days and all developed pellagra between 50 and 60 days, whereas a 
fourth subject who received the corn diet supplemented with 2 mg/day of nicotinamide for 122 days 
(i.e. about 1.2 mg NE/MJ or 5 mg NE/1 000 kcal) did not develop pellagra.  
Goldsmith et al. (1955) studied nine women and one man (aged 26-60 years, some of whom were 
psychiatric or neurology patients) who were given experimental diets for up to 135 days. The diets 
contained approximately 4.7 mg niacin and 190 mg tryptophan (“corn” diet) or approximately 5 mg 
                                                     
14 i.e. “maize” in UK English. 
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niacin and 200 mg tryptophan (“wheat” diet) and about 8.4 MJ; thus, both diets provided 
0.94-0.99 mg NE/MJ (3.9-4.1 mg NE/1 000 kcal) per day. The energy content of the diets was 
adjusted to meet the subjects‟ energy requirements. Three subjects followed the “wheat” diet for 95 to 
105 days, six followed the “corn diet” supplemented with nicotinamide to achieve total niacin intakes 
of 4.6 to 21.2 mg/day (each supplement administered for a period of 12 to 20 days and each subject 
studied at four to six levels of niacin intake) and one followed both (unsupplemented) diets 
alternating every 20 days for 80 days in total. One out of the three subjects on the wheat diet 
(0.99 mg NE/MJ or 4.1 mg NE/1 000 kcal) developed pellagra after 80 days and so did the subject on 
unsupplemented alternating diets. 
Horwitt et al. (1956) studied 40 male psychiatric patients (aged ≥ 30 years except for one subject) 
divided into five groups: one group (n = 9) consuming a general hospital diet (HD) ad libitum 
supplemented with 10 mg/day nicotinamide three times a week and four groups in which the subjects 
consumed, according to “appetite, size and personal preference”, 90 to 120 % of a basal diet 
containing 5.8 mg niacin and 265 mg tryptophan for 9.6 MJ, thus about 1.06 mg NE/MJ 
(4.5 mg NE/1 000 kcal). Among these four groups, two groups were supplemented with 2 mg/day 
riboflavin and either 10 mg/day nicotinamide (n = 7, i.e. about 2.1 mg NE/MJ) or tryptophan (n = 8, 
50 mg/day for 10 weeks, i.e. about 1.15 mg NE/MJ, 100 mg/day afterwards, i.e. about 
1.24 mg NE/MJ). The original design of the study was respected for the first 37 weeks only. No signs 
of pellagra were observed in these patients. Horwitt et al. (1956) also compared their data on niacin 
and tryptophan requirements (n = 15 subjects, followed up to 87 weeks) with those (n = 20) from two 
other similar publications (Frazier and Friedemann, 1946; Goldsmith et al., 1952) and an unpublished 
source. The authors reported that this comparison showed that no signs of pellagra were observed in 
subjects consuming about 8.4-11.5 MJ and 9.2-12.3 mg NE, thus with an intake of about 1 mg NE/MJ 
(4.4 mg NE/1 000 kcal). Horwitt et al. also reported, based on this comparison, that signs of pellagra 
were observed in some subjects (from the other three data sources considered) consuming less than 
8.8 MJ and 7.4-8.2 mg NE or about 12.5 MJ and 12.2 mg NE, thus at an intake of about 
0.9-1 mg NE/MJ (3.7-4.1 mg NE/1 000 kcal), assuming an energy intake of 2 000 kcal for this 
calculation. It was therefore considered that diets providing less than about 8.4 MJ (2 000 kcal) 
should provide at least 8.8 mg NE (Horwitt et al., 1956; Goldsmith, 1958). 
The Panel notes that, in these studies performed on heterogeneous groups of subjects, mostly patients 
for whom no alteration in energy metabolism and niacin requirements is assumed, symptoms of 
pellagra developed in subjects consuming less than about 1 mg NE/MJ for more than 50 days. The 
Panel also notes that, on the basis of its biochemical role and of the results of these studies, niacin 
requirement depends on energy intake, that intakes of about 1-1.2 mg NE/MJ (4.4-
5 mg NE/1 000 kcal) prevented the development of pellagra and that this relationship was established 
for diets that were designed to maintain subjects‟ body weight. 
5.1.1.2. Urinary niacin metabolites 
The Panel considers urinary excretion of niacin metabolites, NMN and 2-Pyr, as a suitable criterion 
for deriving the requirement for niacin and that the other markers of niacin intake/status cannot be 
used as criteria for deriving DRVs for niacin (see Section 2.3.). 
In the depletion–repletion study of Jacob et al. (1989), a “low” intake of 6.1 or 10.1 mg NE/day, i.e. 
below 1 mg NE/MJ, for 35 days resulted in a significant fall in urinary NMN excretion 
(0.80 ± 0.13 mg/day and 0.81 ± 0.14 mg/day, respectively) and 2-Pyr excretion (1.00 ± 0.05 mg/day 
and 3.10 ± 0.71 mg/day, respectively) compared with the excretion of these metabolites (respectively, 
2.90 ± 0.41 and 7.21 ± 1.86 mg/day) on the initial diet (19.6 mg NE/day, about 1.9 mg NE/MJ), while 
no symptoms of pellagra were observed. After two weeks on a “repletion” diet containing 
19.2 mg NE/day (1.8 mg NE/MJ or 7.68 mg NE/1 000 kcal), a significant increase in urinary NMN 
excretion (1.82 ± 0.08 mg/day) compared with the “low” diets was observed, while urinary 2-Pyr 
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excretion was 6.25 ± 0.40 mg/day and thus six-fold (p < 0.05) or two-fold (p > 0.05) higher compared 
with the intakes of 6.1 or 10.1 mg NE/day, respectively. Urinary 2-Pyr excretion over four hours after 
an oral dose of nicotinamide was significantly greater during the initial period of 19.6 mg NE/day 
compared with that at the end of the “depletion” period (intakes of 6.1 or 10.1 mg NE/day) and of the 
“repletion” period (intake of 19.2 mg NE/day). The authors stated that the latter difference may reflect 
an incomplete repletion of niacin body stores. 
In the first phase of the experiment of Goldsmith et al. (1952), during which no signs of pellagra were 
observed, mean urinary NMN concentrations decreased in both subjects on the “corn” diet 
(0.9-1.2 mg/day during the last two weeks) and in the subject on the “wheat” diet (1.1 mg/day during 
the last 33 days), and urinary excretion of 2-Pyr decreased in all three subjects to undetectable 
concentrations after the first two weeks. In the second phase of this experiment, urinary NMN 
excretion decreased to 0.5-0.7 mg/day in all three subjects who developed pellagra on the “corn” diet 
(providing less than about 1 mg NE/MJ) and to 0.9 mg/day in the supplemented subject on the “corn” 
diet without pellagra (i.e. receiving about 1.2 mg NE/MJ), while urinary excretion of 2-Pyr decreased 
to undetectable concentrations in all four subjects.  
In all three subjects on the “wheat” diet (providing less than about 1 mg NE/MJ) (Goldsmith et al., 
1955), urinary NMN excretion decreased gradually around the 80
th
 day down to 0.6-0.8 mg/day while 
2-Pyr excretion decreased to concentrations of about 0.3-0.7 mg/day, but only one subject developed 
pellagra. In the subjects supplemented with nicotinamide to achieve total niacin intakes of 4.6 to 
21.2 mg/day, the relationship between niacin intakes and urinary excretion of niacin metabolites was 
found to differ between niacin intakes up to about 8-10 mg/day and intakes above: about 0.2 mg/day 
of metabolites were excreted per each additional mg of niacin up to the intake of 8-10 mg/day above 
which the excretion significantly increased to 0.6 mg of metabolites per each additional mg of niacin 
intake.  
The Panel notes that an intake of at least 8 mg niacin in addition to the tryptophan intake from the diet 
(about 200 mg), i.e. an intake of at least 11 mg NE/day, which corresponds to 1.3 mg NE/MJ (about 
5.5 mg NE/1 000 kcal), was sufficient to prevent depletion and maintain niacin body stores as 
indicated by a sharp increase in urinary excretion of niacin metabolites above this intake. The Panel 
also notes that diets providing less than about 1 mg NE/MJ (about 4.4 mg NE/1 000 kcal) are 
insufficient to maintain niacin body stores as indicated by significantly lower urinary excretion of  
2-Pyr after oral nicotinamide dose tests.  
5.1.2. Conclusions on indicators of niacin requirement in adults 
Based on the two papers by Goldsmith et al. (1952; 1955) using urinary excretion of niacin 
metabolites as an endpoint, an intake of 1.3 mg NE/MJ (about 5.5 mg NE/1 000 kcal) was sufficient 
to cover the requirement for niacin. The available data (Goldsmith et al., 1952; Goldsmith et al., 1955; 
Horwitt et al., 1956; Jacob et al., 1989) also show that intakes below about 1 mg NE/MJ (about 
4.4 mg NE/1 000 kcal) are insufficient to maintain niacin body stores. No new pertinent data have 
been published since then. 
The Panel concludes that there are no new data to amend the DRVs for niacin (expressed in mg 
NE/MJ) proposed by SCF in 1993. 
5.1.3. Infants 
The Panel is unaware of any data in infants aged 7-11 months on indicators of niacin requirement. 
There is no evidence that the relationship between niacin requirement and energy requirement in 
infants aged 7-11 months differs from that of adults.  
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5.1.4. Children 
The Panel is unaware of any new data in children on indicators of niacin requirement published after 
the report by SCF (1993) which did not cite any specific data for this population group. 
The Panel notes the lack of evidence on indicators of niacin requirement in children. There is no 
evidence that the relationship between niacin requirement and energy requirement in children differs 
from that of adults.  
5.1.5. Pregnancy 
The Panel is unaware of any data in pregnant women on indicators of niacin requirement. There is no 
evidence that the relationship between niacin requirement and energy requirement in pregnancy 
differs from that of non-pregnant women. 
5.1.6. Lactation 
The Panel is unaware of any data in lactating women on indicators of niacin requirement. There is no 
evidence that the relationship between niacin requirement and energy requirements in lactation differs 
from that of non-lactating women. 
5.2. Niacin intake and health consequences 
A comprehensive search of the literature published between January 1990 and January 2012 was 
performed as preparatory work to this assessment in order to identify new data on relevant health 
outcomes upon which DRVs for niacin may potentially be based (Eeuwijk et al., 2012).  
No intervention studies are available on niacin intake and health outcomes. The relationship between 
niacin intakes and chronic disease outcomes has been investigated in observational (case–control, 
cross–sectional, prospective cohort) studies, where an association between niacin intake and disease 
outcomes might be confounded by uncertainties inherent in the methodology used for the assessment 
of niacin intakes and by the effect of other dietary, lifestyle or undefined factors on the health or 
disease outcomes investigated. 
No association was found between niacin intake and all-cause mortality (Huang et al., 2012); breast, 
endometrial, ovarian, colorectal and lung cancer (Sellers et al., 2001; Shin et al., 2006; Kabat et al., 
2008; Shrubsole et al., 2011); cognitive function (Morris et al., 2004; Woo et al., 2006); pneumonia 
(Neuman et al., 2007); ovulatory infertility and premenstrual syndrome (Chocano-Bedoya et al., 
2011); and overactive bladder syndrome (Dallosso et al., 2004; Neuman et al., 2007; Chavarro et al., 
2008; Chocano-Bedoya et al., 2011; Huang et al., 2012). Conflicting results were observed in relation 
to maternal niacin intake and infant birth weight (Weigel et al., 1991; Lagiou et al., 2005). 
Associations between niacin intake and prevalence of nuclear cataract (Cumming et al., 2000) and 
genome stability (Fenech et al., 2005) were reported; however, similar associations with a number of 
other nutrients were noted. 
The Panel considers that the data available on niacin intake and health outcomes cannot be used for 
deriving DRVs for niacin. 
6. Data on which to base Dietary Reference Values 
The Panel notes that no new scientific data that would necessitate an amendment of the AR and PRI 
for niacin have become available since the publication of the SCF report in 1993. The Panel therefore 
endorses the relationship proposed by SCF (1993) between niacin requirement and energy 
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requirement. Niacin requirement is expressed in NE as the sum of preformed niacin plus that provided 
by endogenous synthesis from tryptophan, by energy unit. Taking into account the reference energy 
intake, i.e. the AR for energy, the intake of NE can be expressed as mg NE/day (Appendices G–J). 
The ARs for energy for various Physical Activity Levels (PAL values) can be found in the Scientific 
Opinion on Dietary Reference Values for energy (EFSA NDA Panel, 2013). 
The Panel notes that, as for other nutrient reference values, DRVs for niacin are set under the 
assumption that intakes of other essential nutrients, particularly iron, riboflavin, vitamin B6 and 
protein, and energy are adequate.  
6.1. Adults 
In the absence of new scientific data, the Panel endorses the AR for adults (men and women) adopted 
by SCF (1993) and set at 1.3 mg NE/MJ. The Panel decides to apply the same CV of 10 % as SCF 
(1993) and also endorses the PRI of 1.6 mg NE/MJ (6.6 mg NE/1 000 kcal). The PRIs in mg NE/day 
are presented in Appendix G. 
6.2. Infants 
For infants aged 7-11 months, the Panel considers that there is no evidence that the relationship 
between niacin requirement and energy requirement differs from that of adults. Therefore, for infants, 
the AR and PRI (expressed as mg NE/MJ) for adults are applied. The PRIs in mg NE/day are 
presented in Appendix H.  
6.3. Children 
The Panel considers that there is no evidence that the relationship between niacin requirement and 
energy requirement in children and adolescents differs from that of adults. Therefore, for children and 
adolescents, the AR and PRI (expressed as mg NE/MJ) for adults are applied. The PRIs in mg NE/day 
are presented in Appendix I.  
6.4. Pregnancy 
The Panel considers that there is no evidence that the relationship between niacin requirement and 
energy requirement in pregnancy differs from that of other adults. The Panel notes that the energy 
requirement in pregnant women is increased (by 0.29 MJ/day, 1.1 MJ/day and 2.1 MJ/day, for the 
first, second and third trimesters, respectively) (EFSA NDA Panel, 2013). The PRI in mg NE/day is 
increased proportionally compared with that in non-pregnant women (i.e. using the AR for niacin of 
1.3 mg NE/MJ, the AR for additional energy for pregnancy or lactation and a CV of 10 %), as 
presented in Appendix J. 
6.5. Lactation 
The Panel considers that there is no evidence that the relationship between niacin requirement and 
energy requirement in lactating women differs from that of other adults. The Panel notes that the 
energy requirement in lactation is increased by 2.1 MJ/day (EFSA NDA Panel, 2013). The Panel 
considers that the additional niacin intake in proportion to this additional energy intake covers the 
amount of niacin secreted in breast milk; therefore no further compensation is considered necessary. 
The PRI in mg NE/day is increased compared with that in non-lactating women, as presented in 
Appendix J.  
Dietary Reference Values for niacin 
 
EFSA Journal 2014;12(7):3759 24 
CONCLUSIONS 
The Panel concludes that no new scientific data have become available to change the Population 
Reference Intake (PRI) for niacin set by SCF in 1993, and endorses the PRI at 1.6 mg NE/MJ for all 
population groups.  
Table 5:  Summary of Dietary Reference Values for niacin 
Age PRI 
(mg NE/MJ) 
7 months to ≥ 18 years (a) 1.6 
(a): including pregnancy and lactation. 
NE: niacin equivalent (1 mg niacin = 1 niacin equivalent = 60 mg dietary tryptophan). 
RECOMMENDATIONS FOR RESEARCH 
Future studies should investigate indicators of niacin requirement in infants aged 7-11 months, 
children, and pregnant and lactating women.  
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APPENDICES 
Appendix A.  Niacin content of human milk from healthy mothers 
Reference 
 
Number of 
women (number 
of samples) 
Country Stage of 
lactation 
Niacin 
concentration 
(mg/L) 
Form of 
niacin 
analysed 
    mean range  
Ford et al. (1983) 
(a)
 35 (total) UK    Nicotinic acid 
 7 (18)  1-5 days 0.50 0.30-0.91  
 8 (22)  6-15 days 1.42 0.26-3.00  
 23 (24)  16-244 days 1.82 1.20-2.80  
DHSS (1977) 
(a)
  96 UK 14-63 days 2.3 - Nicotinic acid 
(a) Supplementation status for niacin unknown (not reported). 
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Appendix B.  Dietary surveys from the EFSA Comprehensive Food Consumption Database included in the nutrient intake calculation for niacin 
Country Dietary survey (Year) Year Method Days Age Number of subjects (b) 
  
   
(years) Infants 
6-11 
months 
Children 
1-< 3 
years  
Children  
3-< 10 
years  
Adolescents 
10-< 18 
years  
Adults 
18-< 65 
years  
Adults 
65-< 75 
years  
Adults 
≥ 75 
years  
Finland/1 DIPP 2000-2010 Dietary record 3 < 1-6 499 500 750     
Finland/2 NWSSP 2007-2008 48-hour dietary recall (a) 2x2 (a) 13-15      306    
Finland/3 FINDIET2012 2012 48-hour dietary recall (a) 2 (a) 25-74     1 295 413  
France INCA2 2006-2007 Dietary record 7 3-79   482   973 2 276 264   84 
Germany/1 EsKiMo 2006 Dietary record 3 6-11   835   393    
Germany/2 VELS 2001-2002 Dietary record 6 < 1-4 159 347 299     
Ireland NANS 2008-2010 Dietary record 4 18-90     1 274 149   77 
Italy INRAN-SCAI 2005-06 2005-2006 Dietary record 3 < 1-98   16 (b)   36 (b) 193   247 2 313 290 228 
Latvia FC_PREGNANTWOMEN 2011 2011 24-hour dietary recall 2 15-45        12 (b)    991 (c)   
Netherlands VCPBasis_AVL 2007-2009 24-hour dietary recall 2 7-69   447 1 142 2 057 173  
Sweden RISKMATEN 2010-2011 Dietary records (Web) (d) 4 18-80     1 430 295   72 
United 
Kingdom 
NDNS - 
Rolling Programme (Years 1-3) 
2008-2011 Dietary record 4 1-94  185 651   666 1 266 166 139 
(a): A 48-hour dietary recall comprising two consecutive days. 
(b): 5th or 95th percentile intakes calculated over a number of subjects lower than 60 require cautious interpretation as the results may not be statistically robust (EFSA, 2011b) and therefore for 
these dietary surveys/age classes the 5th and 95th percentile estimates will not be presented in the intake results.  
(c): One subject was excluded from the dataset due to only one 24-hour dietary recall day being available, i.e. the final n = 990. 
(d): The Swedish dietary records were introduced through the Internet. 
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Appendix C.  Total niacin intakes among males in different surveys according to age classes and country (NE, mg/day and mg/MJ) 
Age class Country Survey 
Intakes expressed in mg NE/day Intakes expressed in mg NE/MJ 
N Average Median P5 P95 N Average Median P5 P95 
Infants Finland DIPP_2001_2009 247 10.9   9.8 0.9 24.3 245 3.5 3.4 2.3 5.3 
 
Germany VELS 84   8.7   8.2 4.7 14.2 84 2.6 2.7 1.6 3.5 
 
Italy INRAN_SCAI_2005_06 9   7.2   6.9 (a)  (a)  9 2.1 2.2 (a)  (a)  
Boys 1-< 3 years Finland DIPP_2001_2009 245 18.9 17.5 9.5 33.6 245 3.9 3.9 2.9 5.3 
 
Germany VELS 174 12.9 12.1 7.7 20.5 174 2.7 2.7 1.9 3.7 
 
Italy INRAN_SCAI_2005_06 20 20.1 20.1 (a)  (a)  20 3.9 4.0 (a)  (a)  
 
United Kingdom NDNS-Rolling Programme Years 1-3 107 18.1 17.6 11.5 25.8 107 3.7 3.7 2.7 4.9 
Boys 3-< 10 years Finland DIPP_2001_2009 381 23.3 22.5 14.7 34.7 381 3.9 3.8 2.9 5.1 
 
France INCA2 239 30.4 29.0 16.6 50.1 239 4.8 4.7 3.5 6.4 
 
Germany EsKiMo 426 25.0 24.4 16.5 35.1 426 3.3 3.2 2.4 4.4 
 
Germany VELS 146 15.9 16.1 10.5 22.5 146 2.8 2.8 2.1 3.7 
 
Italy INRAN_SCAI_2005_06 94 31.5 29.5 17.7 49.4 94 4.3 4.3 2.9 6.3 
 
Netherlands VCPBasis_AVL2007_2009 231 25.5 24.5 15.0 38.6 231 3.0 2.9 1.9 4.3 
 
United Kingdom NDNS-Rolling Programme Years 1-3 326 23.4 22.8 13.4 34.6 326 3.8 3.7 2.6 5.4 
Boys 10-< 18 years Finland NWSSP07_08 136 33.3 32.5 19.3 49.0 136 4.1 4.0 2.9 5.6 
 
France INCA2 449 41.0 38.5 25.0 66.3 449 5.2 5.0 3.7 7.1 
 
Germany EsKiMo 197 27.1 25.7 17.2 42.8 197 3.4 3.3 2.3 4.6 
 
Italy INRAN_SCAI_2005_06 108 41.4 40.4 24.7 64.5 108 4.3 4.3 3.2 5.4 
 
Netherlands VCPBasis_AVL2007_2009 566 35.5 33.0 19.9 59.5 566 3.3 3.2 2.1 5.2 
 
United Kingdom NDNS-Rolling Programme Years 1-3 340 31.6 30.5 18.2 47.9 340 4.0 3.9 2.6 5.9 
Men 18-< 65 years Finland FINDIET2012 585 42.6 41.3 22.4 68.9 585 4.7 4.5 2.9 6.9 
 
France INCA2 936 47.3 45.8 27.2 73.6 936 5.4 5.3 3.8 7.7 
 
Ireland NANS_2012 634 53.4 52.0 31.3 77.3 634 5.4 5.2 3.8 7.5 
 
Italy INRAN_SCAI_2005_06 1 068 42.2 40.9 25.7 63.1 1 068 4.8 4.7 3.5 6.7 
 
Netherlands VCPBasis_AVL2007_2009 1 023 46.6 43.9 26.6 76.0 1 023 4.2 4.0 2.7 6.1 
 
Sweden Riksmaten 2010 623 50.1 48.4 26.7 78.2 623 5.1 5.0 3.6 7.4 
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Age class Country Survey 
Intakes expressed in mg NE/day Intakes expressed in mg NE/MJ 
N Average Median P5 P95 N Average Median P5 P95 
 
United Kingdom NDNS-Rolling Programme Years 1-3 560 40.1 38.0 20.5 63.0 560 4.7 4.6 2.8 6.8 
Men 65-< 75 years Finland FINDIET2012 210 35.7 35.1 19.7 56.8 210 4.5 4.4 2.6 6.7 
 
France INCA2 111 45.5 44.7 23.1 72.8 111 5.3 5.1 3.9 7.3 
 
Ireland NANS_2012 72 44.8 44.1 23.8 69.1 72 5.2 5.0 3.4 7.5 
 
Italy INRAN_SCAI_2005_06 133 41.5 41.5 22.7 61.9 133 5.1 5.0 3.7 7.0 
 
Netherlands VCPBasis_AVL2007_2009 91 39.6 38.1 23.2 57.9 91 4.4 4.1 2.7 7.0 
 
Sweden Riksmaten 2010 127 44.5 41.7 28.2 69.6 127 5.2 5.0 3.5 7.0 
 
United Kingdom NDNS-Rolling Programme Years 1-3 75 37.9 37.5 11.7 56.1 75 4.6 4.5 2.5 6.6 
Men ≥ 75 years France INCA2 40 40.2 38.4 (a) (a)  40 5.2 5.1 (a)  (a)  
 
Ireland NANS_2012 34 40.2 41.2 (a)  (a)  34 5.4 5.3 (a)  (a)  
 
Italy INRAN_SCAI_2005_06 69 39.2 36.8 24.5 56.4 69 4.8 4.8 3.5 6.9 
 
Sweden Riksmaten 2010 42 40.3 39.3 (a)  (a)  42 4.8 4.8 (a)  (a)  
 
United Kingdom NDNS-Rolling Programme Years 1-3 56 31.6 29.6 (a)  (a)  56 4.6 4.5 (a)  (a)  
(a): 5th or 95th percentile intakes calculated over a number of subjects lower than 60 require cautious interpretation as the results may not be statistically robust (EFSA, 2011b) and therefore for 
these dietary surveys/age classes the 5th and 95th percentile estimates will not be presented in the intake results. 
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Appendix D.  Total niacin intakes among females in different surveys according to age classes and country (NE, mg/day and mg/MJ) 
Age class Country Survey 
Intakes expressed in mg NE/day Intakes expressed in mg NE/MJ 
N Average Median P5 P95 N Average Median P5 P95 
Infants Finland DIPP_2001_2009 252 10.2 9.3 0.8 22.6 251 3.5 3.4 2.0 5.1 
 
Germany VELS 75 7.6 7.5 4.3 12.0 75 2.5 2.5 1.6 3.4 
 
Italy INRAN_SCAI_2005_06 7 8.2 7.2 (a)  (a)  7 2.7 2.4 (a) (a)  
Girls 1-< 3 years Finland DIPP_2001_2009 255 17.7 16.5 7.4 29.5 255 4.0 3.9 2.8 5.6 
 
Germany VELS 174 11.9 11.7 6.9 17.9 174 2.8 2.7 1.9 3.9 
 
Italy INRAN_SCAI_2005_06 16 17.8 16.3 (a)  (a)  16 3.6 3.8 (a)  (a)  
 
United 
Kingdom NDNS-Rolling Programme Years 1-3 78 16.9 17.0 10.7 22.9 78 3.8 3.6 2.6 5.4 
Girls 3-< 10 years Finland DIPP_2001_2009 369 20.5 20.3 12.9 29.6 369 3.8 3.8 2.9 5.0 
 
France INCA2 243 26.4 25.7 16.7 40.3 243 4.7 4.6 3.5 6.3 
 
Germany EsKiMo 409 22.6 22.1 14.2 34.2 409 3.3 3.2 2.4 4.5 
 
Germany VELS 147 14.3 13.9 9.3 21.0 147 2.8 2.7 1.9 3.8 
 
Italy INRAN_SCAI_2005_06 99 29.9 29.7 17.7 42.5 99 4.2 4.1 3.2 5.6 
 
Netherlands VCPBasis_AVL2007_2009 216 24.2 23.0 14.6 36.4 216 3.0 2.9 1.9 4.3 
 
United 
Kingdom NDNS-Rolling Programme Years 1-3 325 21.6 21.6 12.6 31.5 325 3.7 3.7 2.5 5.2 
Girls 10-< 18 years Finland NWSSP07_08 170 25.4 24.7 15.1 36.6 170 3.9 3.9 2.9 5.0 
 
France INCA2 524 31.7 30.7 17.5 49.3 524 5.0 4.8 3.6 7.0 
 
Germany EsKiMo 196 24.9 24.7 16.0 35.2 196 3.4 3.2 2.5 4.8 
 
Italy INRAN_SCAI_2005_06 139 33.2 32.3 20.1 48.2 139 4.2 4.1 3.2 5.4 
 
Latvia (b) FC_PREGNANTWOMEN_2011 12 38.1 36.4 (a)  (a)  12 3.8 3.9 (a) (a)  
 
Netherlands VCPBasis_AVL2007_2009 576 28.3 27.3 16.0 43.4 576 3.2 3.1 2.1 4.7 
 
United 
Kingdom NDNS-Rolling ProgrammeYears 1-3 326 25.9 25.1 14.4 40.6 326 3.9 3.7 2.5 5.6 
Women 18-< 65 years Finland FINDIET2012 710 31.1 29.6 18.3 46.6 710 4.4 4.2 2.8 6.8 
 
France INCA2 1 340 34.2 33.2 18.9 53.5 1 340 5.3 5.1 3.7 7.6 
 
Ireland NANS_2012 640 35.4 35.0 21.0 53.0 640 4.9 4.7 3.4 6.8 
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Age class Country Survey 
Intakes expressed in mg NE/day Intakes expressed in mg NE/MJ 
N Average Median P5 P95 N Average Median P5 P95 
 
Italy INRAN_SCAI_2005_06 1 245 35.1 34.0 20.8 50.0 1 245 4.8 4.7 3.4 6.6 
 
Latvia (b) FC_PREGNANTWOMEN_2011 990 39.0 37.1 22.1 62.3 990 4.6 4.4 2.8 7.4 
 
Netherlands VCPBasis_AVL2007_2009 1 034 33.0 32.0 18.4 50.9 1 034 4.0 3.8 2.5 6.0 
 
Sweden Riksmaten 2010 807 36.7 35.3 20.8 55.5 807 4.9 4.7 3.3 7.0 
 
United 
Kingdom NDNS-Rolling Programme Years 1-3 706 29.5 29.0 15.1 45.9 706 4.6 4.4 2.8 6.8 
Women 65-< 75 years Finland FINDIET2012 203 27.4 26.0 15.0 42.9 203 4.5 4.3 2.9 6.7 
 
France INCA2 153 32.6 32.0 18.3 50.6 153 5.2 5.2 3.8 7.1 
 
Ireland NANS_2012 77 34.6 35.4 21.1 46.8 77 5.2 5.0 3.9 7.0 
 
Italy INRAN_SCAI_2005_06 157 33.6 33.4 17.9 49.0 157 5.1 4.8 3.6 7.1 
 
Netherlands VCPBasis_AVL2007_2009 82 30.7 28.9 17.8 45.3 82 4.2 4.1 2.8 5.9 
 
Sweden Riksmaten 2010 168 35.5 34.0 21.0 55.2 168 5.1 4.9 3.8 6.8 
 
United 
Kingdom NDNS-RollingProgramme Years 1-3 91 30.0 29.3 19.2 41.6 91 5.1 5.1 3.5 7.1 
Women ≥ 75 years France INCA2 44 30.6 30.1 (a)  (a)  44 5.1 5.2 (a)  (a)  
 
Ireland NANS_2012 43 32.5 30.3 (a)  (a)  43 5.2 5.1 (a) (a)  
 
Italy INRAN_SCAI_2005_06 159 32.0 31.6 18.7 45.8 159 4.8 4.7 3.5 6.6 
 
Sweden Riksmaten 2010 30 35.4 35.6 (a) (a)  30 5.1 4.8 a a 
 
United 
Kingdom NDNS-Rolling Programme Years 1-3 83 27.8 27.0 17.4 37.3 83 4.7 4.6 3.0 6.5 
(a): 5th or 95th percentile intakes calculated over a number of subjects lower than 60 require cautious interpretation as the results may not be statistically robust (EFSA, 2011b) and therefore for 
these dietary surveys/age classes the 5th and 95th percentile estimates will not be presented in the intake results. 
(b): Pregnant women only. 
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Appendix E.  Minimum and maximum percentage contribution of different FoodEx2 level1 food groups to niacin intakes among males 
Food groups Infants 
Children 
1-< 3 years  
Children 
3-< 10 years  
Adolescents 
10-< 18 
years  
Adults 
18-< 65 
years  
Adults 
65-< 75 
years  
Adults 
≥ 75 years  
Additives, flavours, baking and processing aids < 0.1 < 0.1 - 0.2 0 - 0.8 0 - 1.3 0 - 0.2 0 0 
Alcoholic beverages < 0.1 < 0.1 < 0.1 < 0.1 - 1.9 0.1 - 7.7 0.1 - 5.7 0.1 - 3.5 
Animal and vegetable fats and oils 0 - 0.1 < 0.1 - 0.1 < 0.1 - 0.2 < 0.1 - 0.2 < 0.1 - 0.2 < 0.1 - 0.3 < 0.1 - 0.3 
Coffee, cocoa, tea and infusions 0 < 0.1 - 0.2 0.3 - 1.4 0.7 - 2.2 2.6 - 12.9 3.8 - 12.6 3.5 - 10.9 
Composite dishes 0 - 0.7 0.6 - 10.7 0.2 - 10.4 0.5 - 13 0.7 - 13.6 1.3 - 12.2 1.5 - 11.9 
Eggs and egg products 0.1 - 0.3 0.4 - 1.9 0.1 - 3 0.1 - 2.9 < 0.1 - 2.3 <0.1 - 2.3 0.1 - 2.1 
Fish, seafood, amphibians, reptiles and invertebrates 0.3 - 1.1 1.5 - 3.9 1.2 - 5.9 1.2 - 6.3 2.3 - 6.9 3.4 - 10.2 4.1 - 12.7 
Food products for young population 33.3 - 43.1 1.7 - 16.2 < 0.1 - 0.6 < 0.1 - 0.1 < 0.1 -(a) -(a) 
Fruit and fruit products 1.9 - 5.1 2.4 - 4.8 1.2 - 3.4 0.9 - 2.3 0.8 - 1.9 1.4 - 2.5 1.2 - 2.9 
Fruit and vegetable juices and nectars 0.3 - 4.5 0.5 - 7.4 1 - 5.4 1 - 4.7 0.5 - 1.6 0.3 - 1.3 0.1 - 1.6 
Grains and grain-based products 5.5 - 13 11.1 - 28.8 13.8 - 33.5 14.5 - 34 15.9 - 29.2 15.3 - 31.9 15.7 - 32.5 
Human milk < 0.1 - 39.8 < 0.1 - 1.3 -(a) -(a) -(a) -(a) -(a) 
Legumes, nuts, oilseeds and spices 0.2 - 0.8 0.7 - 2 0.9 - 3.5 0.7 - 3.5 0.8 - 3.7 0.8 - 3.2 0.5 - 1.9 
Meat and meat products 1.5 - 13.4 15.8 - 24 21.7 - 32.7 22.1 - 36.1 23.6 - 34.7 24.6 - 32.4 22.2 - 31.8 
Milk and dairy products 8.7 - 32 19.1 - 33.7 12.1 - 30.2 9.3 - 23.2 7.2 - 14.5 6.9 - 14.1 7.3 - 10 
Products for non-standard diets, food imitates and food supplements or fortifying 
agents 0 - 0.3 0 - 0.1 0.1 - 0.6 < 0.1 - 0.5 < 0.1 - 1.6 < 0.1 - 0.3 0 - 0.1 
Seasoning, sauces and condiments 0.1 - 0.4 0.1 - 1.5 0.1 - 1.2 0.1 - 1.1 0.1 - 0.9 0.1 - 1 0.1 - 2 
Starchy roots or tubers and products thereof, sugar plants 0.7 - 6.4 2.6 - 7 2.8 - 11.1 2.5 - 12.3 2.7 - 8.7 3.4 - 8.5 3.9 - 7.6 
Sugar, confectionery and water-based sweet desserts 0 - 0.1 < 0.1 - 1.8 0.2 - 2.6 0.2 - 2.4 0.1 - 0.5 0.1 - 0.3 < 0.1 - 0.3 
Vegetables and vegetable products 0.7 - 3.8 2.6 - 3.8 2.3 - 4.3 2.2 - 5.2 1.5 - 6 1.6 - 5.9 1.9 - 5.8 
Water and water-based beverages 0 0 - 0.3 < 0.1 - 4.5 0.1 - 7.4 0.2 - 4.1 < 0.1 - 0.5 < 0.1 - 0.6 
(a): „-‟ means that there was no consumption event of the food group for the age and sex group considered, while „0‟ means that there were some consumption events, but that the food group 
does not contribute to the intake of the nutrient considered, for the age and sex group considered. 
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Appendix F.  Minimum and maximum percentage contribution of different FoodEx2 level1 food groups to niacin intakes among females 
Food groups Infants 
Children 
1-< 3 years 
Children 
3-< 10 years 
Adolescents 
10-< 18 
years 
Adults 
18-< 65 
years 
Adults 
65-< 75 
years 
Adults 
≥ 75 years 
Additives, flavours, baking and processing aids < 0.1 0 - 0.2 0 - 0.9 0 - 1.3 0 - 0.2 < 0.1 0 
Alcoholic beverages < 0.1 < 0.1 < 0.1 < 0.1 - 0.2 < 0.1 - 2 < 0.1 - 1.1 < 0.1 - 0.7 
Animal and vegetable fats and oils < 0.1 - 0.1 < 0.1 - 0.2 < 0.1 - 0.3 < 0.1 - 0.2 < 0.1 - 0.2 < 0.1 - 0.3 < 0.1 - 0.3 
Coffee, cocoa, tea and infusions 0 < 0.1 - 0.2 0.2 - 1.5 0.6 - 3.8 3.9 - 13.6 4.7 - 13.5 5.5 - 11.2 
Composite dishes 0 - 0.3 0.8 - 9.4 0.2 - 10.7 0.8 - 13.5 0.8 - 14.5 0.8 - 12.2 0.9 - 13.2 
Eggs and egg products < 0.1 - 0.5 0.4 - 2.2 0.1 - 3 0.1 - 2.9 0.1 - 2.1 0.1 - 2.1 0.1 - 2.4 
Fish, seafood, amphibians, reptiles and invertebrates 0.2 - 4.5 1.3 - 8.2 0.5 - 4.7 1.1 - 7.6 3.1 - 7.9 4 - 11.1 4.7 - 11.7 
Food products for young population 24.6 - 51.8 2.7 - 11.4 0.1 - 0.3 < 0.1 - 0.1 < 0.1 -(a) < 0.1 
Fruit and fruit products 2.7 - 5.1 2.4 - 4.4 1.5 - 3.7 1.2 - 3.5 1.4 - 2.8 2 - 3.5 1.9 - 3.7 
Fruit and vegetable juices and nectars < 0.1 - 1.8 0.5 - 5.1 0.8 - 5.2 0.8 - 4.1 0.4 - 1.7 0.4 - 1.5 0.4 - 1 
Grains and grain-based products 6.2 - 13.2 11.7 - 30.5 14.4 - 32.8 16.7 - 33.5 16.8 - 30.3 14.8 - 28.5 15.2 - 31.7 
Human milk < 0.1 - 17.3 < 0.1 -(a) -(a) -(a) -(a) -(a) 
Legumes, nuts, oilseeds and spices 0.2 - 1.9 0.6 - 1.9 0.9 - 2.7 0.8 - 2.7 1 - 2.7 1.1 - 2.3 0.8 - 1.2 
Meat and meat products 3.6 - 12.2 17.8 - 21.6 20.5 - 31.5 22.3 - 32.8 22.9 - 32.9 20.9 - 31.8 20 - 33.6 
Milk and dairy products 4.6 - 40.6 17.8 - 39.5 11.8 - 31.6 8.8 - 23.1 8.3 - 16.2 8.8 - 15.5 9.1 - 12.7 
Products for non-standard diets, food imitates and food supplements or fortifying 
agents 0 - 0.3 0 - 0.4 0.1 - 0.7 < 0.1 - 0.6 0.1 - 1.4 < 0.1 - 0.6 0 - 1 
Seasoning, sauces and condiments 0.1 - 0.2 0.1 - 0.9 0.2 - 1.2 0.1 - 1.2 0.1 - 1.2 0.1 - 1.3 0.1 - 1 
Starchy roots or tubers and products thereof, sugar plants 2.8 - 6.2 3 - 6.2 3.1 - 12.2 3.2 - 11.9 3.1 - 7.6 3.8 - 6.4 3.7 - 6.6 
Sugar, confectionery and water-based sweet desserts 0 - 0.5 < 0.1 - 1.7 0.3 - 2.5 0.3 - 2.6 0.1 - 1.2 0.1 - 0.4 0.1 - 0.5 
Vegetables and vegetable products 1.7 - 4.1 2.5 - 4.1 2.2 - 5 2.2 - 5.3 2.4 - 6.4 2.5 - 7 2.6 - 6 
Water and water-based beverages 0 - 0.1 0 - 0.3 < 0.1 - 4 0 - 5 < 0.1 - 3.2 < 0.1 - 0.5 < 0.1 - 0.1 
(a): „-‟ means that there was no consumption event of the food group for the age and sex group considered, while „0‟ means that there were some consumption events, but that the food group 
does not contribute to the intake of the nutrient considered, for the age and sex group considered. 
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Appendix G.  Summary of Population Reference Intakes (PRIs) for niacin for adults expressed 
in mg NE/day 
Age  PRI at PAL = 1.4 
(mg NE/day)
 (a)
 
PRI at PAL = 1.6 
(mg NE/day) 
(a)
 
PRI at PAL = 1.8 
(mg NE/day) 
(a)
 
PRI at PAL = 2.0 
(mg NE/day) 
(a)
 
 Men Women  Men Women  Men Women  Men Women  
18-29 years 15.3 12.3 17.4 14.0 19.6 15.8 21.8 17.5 
30-39 years 14.8 11.8 16.9 13.5 19.0 15.2 21.1 16.9 
40-49 years 14.6 11.7 16.7 13.4 18.7 15.1 20.8 16.8 
50-59 years 14.4 11.6 16.4 13.3 18.5 15.0 20.6 16.6 
60-69 years 13.2 10.6 15.0 12.1 16.9 13.7 18.8 15.2 
70-79 years 12.9 10.5 14.8 12.0 16.6 13.5 18.5 15.0 
(a): The ARs for niacin in mg NE/day were calculated from the AR for niacin of 1.3 mg NE/MJ using the ARs for energy for 
adults according to the Scientific Opinion on Dietary Reference Values for energy (EFSA NDA Panel, 2013), and the 
PRIs were calculated assuming a CV of 10 %. 
PAL: physical activity level. 
 
Appendix H.  Summary of Population Reference Intakes (PRIs) for niacin for infants aged 7-
11 months expressed in mg NE/day  
Age PRI (mg NE/day) 
(a)
 
 Boys Girls 
  7 months 4.2 3.7 
  8 months 4.4 3.9 
  9 months 4.5 4.0 
10 months 4.7 4.2 
11 months 4.8 4.4 
(a): The ARs for niacin in mg NE/day were calculated from the AR for niacin of 1.3 mg NE/MJ using the ARs for energy for 
infants aged 7-11 months according to the Scientific Opinion on Dietary Reference Values for energy (EFSA NDA 
Panel, 2013), and the PRIs were calculated assuming a CV of 10 %. 
 
Dietary Reference Values for niacin 
 
EFSA Journal 2014;12(7):3759 40 
Appendix I.  Summary of Population Reference Intakes (PRIs) for niacin for children and 
adolescents expressed in mg NE/day 
Age  PRI at PAL = 1.4 
(mg NE/day)
 (a)
 
PRI at PAL = 1.6 
(mg NE/day) 
(a)
 
PRI at PAL = 1.8 
(mg NE/day) 
(a)
 
PRI at PAL = 2.0 
(mg NE/day) 
(a)
 
 Boys Girls Boys Girls Boys Girls Boys Girls 
  1 year   5.1   4.6       
  2 years   6.7   6.2       
  3 years   7.7   7.2       
  4 years   8.2   7.6   9.4   8.7 10.5   9.8   
  5 years   8.7   8.1   9.9   9.2 11.2 10.4   
  6 years   9.2   8.6 10.5   9.8 11.8 11.0   
  7 years   9.8   9.1 11.2 10.4 12.6 11.7   
  8 years 10.4   9.6 11.9 11.0 13.4 12.4   
  9 years 11.0 10.2 12.6 11.7 14.1 13.1   
10 years   12.6 11.9 14.2 13.4 15.8 13.4 
11 years   13.3 12.5 15.0 14.0 16.7 14.0 
12 years   14.2 13.1 16.0 14.7 17.7 14.7 
13 years   15.2 13.7 17.1 15.4 19.0 15.4 
14 years   16.4 14.2 18.5 16.0 20.5 16.0 
15 years   17.6 14.5 19.8 16.4 22.0 16.4 
16 years   18.6 14.7 20.9 16.6 23.2 16.6 
17 years   19.2 14.9 21.6 16.7 24.0 16.7 
(a): The ARs for niacin in mg NE/day were calculated from the AR for niacin of 1.3 mg NE/MJ using the AR for energy for 
children and adolescents according to the Scientific Opinion on Dietary Reference Values for energy (EFSA NDA 
Panel, 2013), and the PRIs were calculated assuming a CV of 10 %. 
PAL: physical activity level. 
 
Appendix J.  Summary of Population Reference Intakes (PRIs) for niacin for pregnant and 
lactating women (in addition to the PRI for non-pregnant non-lactating women) expressed 
in mg NE/day 
 PRI 
(a) 
(mg NE/day) 
Pregnant women  
1
st
 trimester + 0.5 
2
nd
 trimester + 1.7 
3
rd
 trimester + 3.3 
Lactating women  
0-6 months post partum + 3.3 
(a): The additional ARs for niacin in mg NE/day were calculated from the AR for niacin of 1.3 mg NE/MJ using the AR for 
additional energy for pregnancy or lactation (i.e. in addition to the AR for energy for non-pregnant non-lactating 
women) according to the Scientific Opinion on Dietary Reference Values for energy (EFSA NDA Panel, 2013), and the 
PRIs (to be added to the PRI for non-pregnant non-lactating women) were calculated assuming a CV of 10 %. 
Dietary Reference Values for niacin 
 
EFSA Journal 2014;12(7):3759 41 
ABBREVIATIONS 
2-Pyr N-methyl-2-pyridone-carboxamide 
4-Pyr N-methyl-4-pyridone-carboxamide 
Afssa Agence française de sécurité sanitaire des aliments 
AI Adequate Intake 
AR Average Requirement 
ATP Adenosine triphosphate 
COMA Committee on Medical Aspects of Food Policy 
CV Coefficient of Variation 
D-A-CH Deutschland-Austria-Confoederatio Helvetica 
DIPP Diabetes Prediction and Prevention Nutrition Study (DIPP) 
DNA Deoxyribonucleic acid 
DH Department of Health 
DRV Dietary Reference Value  
EAR Estimated Average Requirement 
EC European Commission 
EFSA European Food Safety Authority 
EsKiMo Ernährungsstudie als KiGGS-Modul  
EU European Union 
FAO Food and Agriculture Organization 
FINDIET The National Dietary Survey of Finland 
HD Hospital diet 
hOAT10 Human organic anion transporter 10 
INCA Étude Individuelle Nationale des Consommations Alimentaires 
INRAN Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione 
IOM U.S. Institute of Medicine of the National Academy of Sciences 
LTI Lowest Threshold Intake 
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NAD Nicotinamide adenine dinucleotide 
NADH Reduced nicotinamide adenine dinucleotide 
NADP Nicotinamide adenine dinucleotide phosphate 
NADPH Reduced nicotinamide adenine dinucleotide phosphate 
NANS National Adult Nutrition Survey  
NDNS National Diet and Nutrition Survey 
NE Niacin equivalent 
NL Health Council of the Netherlands 
NMN N-methyl-nicotinamide 
NNR Nordic Nutrition Recommendations 
NOAEL No Observed Adverse Effect Level 
NWSSP Nutrition and Wellbeing of Secondary School Pupils 
PAL Physical activity level  
PRI Population Reference Intake 
RDA Recommended Dietary Allowance 
RI Recommended Intake 
SCAI Studio sui Consumi Alimentari in Italia 
SCF Scientific Committee for Food 
UL Tolerable Upper Intake Level 
VCP Voedselconsumptiepeiling 
VELS Verzehrsstudie zur Ermittlung der Lebensmittelaufnahme von 
Säuglingen und Kleinkindern für die Abschätzung eines akuten 
Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln 
WHO World Health Organization 
 
